NGNE · Insider trading · 13F holders · Congress trades
Neurogene Inc. (NGNE)
Who is buying and selling NGNE: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 9
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 0
NGNE at a glance
- No open-market insider purchases or sales of NGNE were filed in the last 90 days.
- 9 13F filers hold NGNE among their 50 largest positions, worth $297.4M combined, including Oleg Nodelman and Julian and Felix Baker. The biggest bets by portfolio weight are Samsara Biocapital, LLC (4.4%), Trails Edge Capital Partners, LP (3.6%) and Redmile Group, LLC (3.0%). In their latest 13Fs, 0 managers opened a new position and 1 added to one.
- No member of Congress has disclosed a trade in NGNE.
NGNE insider trading
No open-market insider purchases or sales of NGNE were filed in the last 90 days.
Who owns NGNE? Hedge funds and superinvestors
9 13F filers hold NGNE among their 50 largest positions, worth $297.4M combined, including Oleg Nodelman and Julian and Felix Baker. The biggest bets by portfolio weight are Samsara Biocapital, LLC (4.4%), Trails Edge Capital Partners, LP (3.6%) and Redmile Group, LLC (3.0%). In their latest 13Fs, 0 managers opened a new position and 1 added to one.
Superinvestors holding NGNE: Oleg Nodelman 2.0% · Julian and Felix Baker 0.2%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Samsara Biocapital, LLCHedge fund | 4.4% | $54.0M | 1,717,127 | +0.0% shares | Q2 2026 |
| Casdin Capital, LLCHedge fund | 2.4% | $48.6M | 1,545,361 | +8.8% shares | Q2 2026 |
| Redmile Group, LLCHedge fund | 3.0% | $44.4M | 1,412,199 | -3.2% shares | Q2 2026 |
| Rtw Investments, LPHedge fund | 0.4% | $42.8M | 1,362,456 | — | Q2 2026 |
| Oleg NodelmanHedge fund | 2.0% | $40.0M | 1,271,342 | +0.0% shares | Q2 2026 |
| Julian and Felix BakerHedge fund | 0.2% | $31.2M | 991,691 | — | Q2 2026 |
| Trails Edge Capital Partners, LPHedge fund | 3.6% | $22.5M | 714,885 | -8.7% shares | Q2 2026 |
| Great Point Partners LLCHedge fund | 2.6% | $11.1M | 352,180 | -29.6% shares | Q2 2026 |
| DAFNA Capital Management LLCHedge fund | 0.5% | $2.8M | 89,032 | — | Q2 2026 |
Each manager counts with its latest 13F (Q2 2026: 9). Screen NGNE in the grand portfolio →
NGNE stock trades by members of Congress
No member of Congress has disclosed a trade in NGNE.
NGNE questions and answers
Are insiders buying NGNE stock?
No open-market insider purchases or sales of NGNE were filed in the last 90 days.
Which hedge funds own NGNE?
9 13F filers hold NGNE among their 50 largest positions, worth $297.4M combined, including Oleg Nodelman and Julian and Felix Baker. The biggest bets by portfolio weight are Samsara Biocapital, LLC (4.4%), Trails Edge Capital Partners, LP (3.6%) and Redmile Group, LLC (3.0%). In their latest 13Fs, 0 managers opened a new position and 1 added to one.
Has Congress traded NGNE?
No member of Congress has disclosed a trade in NGNE.
Who is the largest holder of NGNE?
Among 13F filers, Samsara Biocapital, LLC reports the largest NGNE position, $54.0M (1,717,127 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Samsara Biocapital, LLC's: 4.4% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.